97 related articles for article (PubMed ID: 9415568)
1. Impairment of fibrinolytic potential in long-term steroid treatment after heart transplantation.
Patrassi GM; Sartori MT; Livi U; Casonato A; Danesin C; Vettore S; Girolami A
Transplantation; 1997 Dec; 64(11):1610-4. PubMed ID: 9415568
[TBL] [Abstract][Full Text] [Related]
2. Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation.
Sartori TM; Maurizio PG; Sara P; Ugolino L; Annalisa A; Panagiotis T; Massimo F; Antonio G
J Heart Lung Transplant; 1999 Jul; 18(7):693-700. PubMed ID: 10452346
[TBL] [Abstract][Full Text] [Related]
3. Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy.
Sartori MT; Rigotti P; Marchini F; Spiezia L; Baldan N; Furian L; Varvarikis C; Girolami A
Transplantation; 2003 Apr; 75(7):994-8. PubMed ID: 12698086
[TBL] [Abstract][Full Text] [Related]
4. Improved fibrinolytic capacity after withdrawal of steroid immunosuppression in renal transplant recipients.
Sartori MT; Patrassi GM; Rigotti P; Marchini F; Fioretti M; Spiezia L; Girolami A
Transplantation; 2000 May; 69(10):2116-21. PubMed ID: 10852608
[TBL] [Abstract][Full Text] [Related]
5. Reduced fibrinolytic potential one year after kidney transplantation. Relationship to long-term steroid treatment.
Patrassi GM; Sartori MT; Rigotti P; Di Landro D; Theodoridis P; Fioretti M; Capalbo M; Saggiorato G; Boeri G; Girolami A
Transplantation; 1995 May; 59(10):1416-20. PubMed ID: 7770928
[TBL] [Abstract][Full Text] [Related]
6. The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state.
Patrassi GM; Sartori MT; Viero ML; Scarano L; Boscaro M; Girolami A
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):789-93. PubMed ID: 1489900
[TBL] [Abstract][Full Text] [Related]
7. The effect of cyclosporine on regulators of fibrinolysis in plasma from renal allograft recipients.
Elhasade AS; Perkowska A; Paczek L; Rowiński W; Soluch L; Szmidt J; Gałazka Z; Gaciong Z
Ann Transplant; 1998; 3(1):13-8. PubMed ID: 9869892
[TBL] [Abstract][Full Text] [Related]
8. Some aspects of hemostasis in kidney transplant recipients maintained on cyclosporine, azathioprine, and prednisone in comparison to patients treated with cyclosporine and prednisone.
Malyszko J; Malyszko JS; Hryszko T; Mysliwiec M
Transplant Proc; 2003 Dec; 35(8):2940-2. PubMed ID: 14697944
[TBL] [Abstract][Full Text] [Related]
9. The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipients.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplantation; 1996 Sep; 62(6):828-30. PubMed ID: 8824484
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients.
van den Dorpel MA; Veld AJ; Levi M; ten Cate JW; Weimar W
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1555-8. PubMed ID: 10364089
[TBL] [Abstract][Full Text] [Related]
11. Impaired fibrinolysis in cyclosporine-treated renal transplant patients. Analysis of the defect and beneficial effect of fish-oil.
Levi M; Wilmink J; Büller HR; Surachno J; ten Cate JW
Transplantation; 1992 Dec; 54(6):978-83. PubMed ID: 1465791
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients.
van den Dorpel MA; Levi M; IJzermans JN; ten Cate JW; Weimar W
Transplant Proc; 1999; 31(1-2):329. PubMed ID: 10083130
[No Abstract] [Full Text] [Related]
13. [Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis].
Opatrný K; Vít L; Opatrná S; Sulková S; Bodláková B
Cas Lek Cesk; 1994 May; 133(11):346-9. PubMed ID: 8004664
[TBL] [Abstract][Full Text] [Related]
14. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
[TBL] [Abstract][Full Text] [Related]
15. The effect of chronic allograft rejection on plasma regulators of fibrinolysis.
Perkowska A; Elhasade A; Durlik M; Placha G; Gałazka Z; Lao M; Gaciong Z
Ann Transplant; 2002; 7(1):44-51. PubMed ID: 12221903
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolysis in chronic renal failure, dialysis and renal transplantation.
Opatrný K; Zemanová P; Opatrná S; Vít L
Ann Transplant; 2002; 7(1):34-43. PubMed ID: 12221902
[TBL] [Abstract][Full Text] [Related]
17. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasminogen activator inhibitor levels in cyclosporin-treated renal allograft recipients.
Verpooten GA; Cools FJ; Van der Planken MG; Bedert LC; Claes R; Van Gaal LF; De Broe ME
Nephrol Dial Transplant; 1996 Feb; 11(2):347-51. PubMed ID: 8671791
[TBL] [Abstract][Full Text] [Related]
19. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
20. Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators.
Shahar E; Folsom AR; Salomaa VV; Stinson VL; McGovern PG; Shimakawa T; Chambless LE; Wu KK
Circulation; 1996 Jun; 93(11):1970-5. PubMed ID: 8640970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
